Long-term remission in an aggressive Crooke cell adenoma of the pituitary , 18 months after discontinuation of treatment with temozolomide
Article first published online: 9 DEC 2013
© 2013 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Clinical Case Reports
Volume 2, Issue 1, pages 1–3, February 2014
How to Cite
Clinical Case Reports 2014; 2(1): 1–3
- Issue published online: 6 FEB 2014
- Article first published online: 9 DEC 2013
- Manuscript Accepted: 23 OCT 2013
- Manuscript Revised: 13 OCT 2013
- Manuscript Received: 23 SEP 2013
- Crook's cell adenoma;
- Cushing's disease;
Key Clinical Message
The clinical course of our patient, who sustained remission status for at least 18 months highlights the chance of long-term hormonal and tumor remission and demonstrates the efficacy and safety of discontinuation of temozolomide therapy. Prospective studies are required in order to define predictors of long-term remission of this promising therapeutic modality.